Related references
Note: Only part of the references are listed.Pathological sequelae of long-haul COVID
Saurabh Mehandru et al.
NATURE IMMUNOLOGY (2022)
Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization
Ameya S. Kulkarni et al.
AGING CELL (2022)
Repurposing drugs to fight aging: The difficult path from bench to bedside
Alexander Vaiserman et al.
MEDICINAL RESEARCH REVIEWS (2021)
Strategies for late phase preclinical and early clinical trials of senolytics
Erin O. Wissler Gerdes et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials
Sergei Romashkan et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2021)
Rapamycin Added to Diet in Late Mid-Life Delays Age-Related Hearing Loss in UMHET4 Mice
Richard A. Altschuler et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
A TORC1-histone axis regulates chromatin organisation and non-canonical induction of autophagy to ameliorate ageing
Yu-Xuan Lu et al.
ELIFE (2021)
Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition
Alessandro Bitto et al.
FRONTIERS IN AGING (2021)
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
Sieta T. de Vries et al.
DRUG SAFETY (2020)
From causes of aging to death from COVID-19
Mikhail V. Blagosklonny
AGING-US (2020)
The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Effect of caloric restriction and rapamycin on ovarian aging in mice
Driele N. Garcia et al.
GEROSCIENCE (2019)
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
Ellen Kraig et al.
EXPERIMENTAL GERONTOLOGY (2018)
Short-term Low-Dose mTORC1 Inhibition in Aged Rats Counter-Regulates Age-Related Gene Changes and Blocks Age-Related Kidney Pathology
Tea Shavlakadze et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
TORC1 inhibition enhances immune function and reduces infections in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Development of clinical trials to extend healthy lifespan
Jamie N. Justice et al.
CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM (2018)
Prevention of Stomatitis Using dexamethasone-based mouthwash to inhibit everolimus-related stomatitis
Babita Saigal et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2018)
Rapamycin treatment attenuates age-associated periodontitis in mice
Jonathan Y. An et al.
GEROSCIENCE (2017)
A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
Silvan R. Urfer et al.
GEROSCIENCE (2017)
Geroscience and the trans-NIH Geroscience Interest Group, GSIG
Felipe Sierra et al.
GEROSCIENCE (2017)
Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes
Kavithalakshmi Sataranatarajan et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts
Ying Ann Chiao et al.
AGING-US (2016)
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
Brian K. Kennedy et al.
CELL METABOLISM (2016)
Rapamycin Attenuates Age-associated Changes in Tibialis Anterior Tendon Viscoelastic Properties
Lauren Wood Zaseck et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
The Emergence of Geroscience as an Interdisciplinary Approach to the Enhancement of Health Span and Life Span
Felipe Sierra
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
Alessandro Bitto et al.
ELIFE (2016)
Healthy aging: The ultimate preventative medicine
Matt Kaeberlein et al.
SCIENCE (2015)
Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart
Dao-Fu Dai et al.
AGING CELL (2014)
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
Richard A. Miller et al.
AGING CELL (2014)
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
Irina G. Popovich et al.
CANCER BIOLOGY & THERAPY (2014)
Geroscience: Linking Aging to Chronic Disease
Brian K. Kennedy et al.
CELL (2014)
Rapamycin Extends Life and Health in C57BL/6 Mice
Yiqiang Zhang et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
Wilson C. Fok et al.
PLOS ONE (2014)
Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice
Kassem Makki et al.
PLOS ONE (2014)
mTOR inhibition improves immune function in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Late-life rapamycin treatment reverses age-related heart dysfunction
James M. Flynn et al.
AGING CELL (2013)
Rapamycin extends life span of Rb1+/- mice by inhibiting neuroendocrine tumors
Carolina B. Livi et al.
AGING-US (2013)
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1ß and enhancing NMDA signaling
Smita Majumder et al.
AGING CELL (2012)
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice
Elena A. Komarova et al.
AGING-US (2012)
TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
Stacey Robida-Stubbs et al.
CELL METABOLISM (2012)
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake
Oemer H. Yilmaz et al.
NATURE (2012)
CHRONIC INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN BY RAPAMYCIN MODULATES COGNITIVE AND NON-COGNITIVE COMPONENTS OF BEHAVIOR THROUGHOUT LIFESPAN IN MICE
J. Halloran et al.
NEUROSCIENCE (2012)
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Vladimir N. Anisimov et al.
CELL CYCLE (2011)
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Richard A. Miller et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Clinical presentation and management of mTOR inhibitor-associated stomatitis
Marcio Augusto de Oliveira et al.
ORAL ONCOLOGY (2011)
Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
Ivana Bjedov et al.
CELL METABOLISM (2010)
Rapamycin Protects Against High Fat Diet-Induced Obesity in C57BL/6J Mice
Geng-Ruei Chang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
David E. Harrison et al.
NATURE (2009)
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chong Chen et al.
SCIENCE SIGNALING (2009)
MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae
Oliver Medvedik et al.
PLOS BIOLOGY (2007)
Extension of chronological life span in yeast by decreased TOR pathway signaling
RW Powers et al.
GENES & DEVELOPMENT (2006)
Benefit-risk assessment of sirolimus in renal transplantation
DRJ Kuypers
DRUG SAFETY (2005)
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
SH Um et al.
NATURE (2004)
Share Paper
